Apr 09, 2020 Dear Savio, To borrow from Charles Dickens, the current moment may be both “the best of times” and “the worst of times.” But for most of us, it feels quite simply like the worst of times. We are terrified of threats to our physical health… and to our financial health. Worst of all, the immediate future seems as uncertain as an uncertain future could possibly be. “The virus decides,” as Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, has stated repeatedly. And very few of us have any idea what it means to place our well-being in the hands of a virus. That’s scary… and completely unpredictable. So what factors could possibly combine to make the current moment the “best of times”? For starters, the coronavirus epidemic has shined a spotlight on the best of human nature. Stories of extraordinary compassion and self-sacrifice are multiplying faster than the virus itself. Second, the “shelter in place” lifestyle is fostering a wide array of innovations and creative work-arounds. Some of these novel solutions and inventions are producing unexpected efficiencies in various business processes. Others are fostering surprisingly dynamic and vibrant modes of social interaction. .jpg) More importantly, the current moment may be the best of times because of the awe-inspiring scientific energy it has unleashed. Medical researchers throughout the entire world are working 24/7 to develop vaccines and treatments for COVID-19.
And perhaps most importantly, the urgent race to find a vaccine and/or treatment for COVID-19 is pressuring the U.S. Food and Drug Administration to accelerate the processes by which pharmaceutical innovation advances to commercial therapies. To be sure, effective vaccines and/or treatments for the coronavirus cannot arrive soon enough. And the road toward success will be a tortuous one. But an eventual victory seems all but certain. Finally, great investment opportunities are emerging. While the broad stock market averages have fallen as much as 34% from their February record highs, many individual stocks have tumbled twice as much… or more. These harrowing selloffs are presenting the best buying opportunities since 2009. Obviously, it is much easier to suggest buying stocks during a volatile bear market than it is to part with actual cash to buy a stock. The advice to buy is clinical. Actually buying is visceral – and potentially painful. Therefore, to bridge the gap between theory and practice, in the April issue of Fry’s Investment Report, we’ll turn to the real-world experiences and insights of a few investing legends. We’ll take a look at a few of their past successes… failures… and successes that looked like failures at the outset. Here’s what else you’ll find in this month’s issue… - In a Crisis, the Painful Short Term Will Lead to a Profitable Long Term
- Bear Market Bravado… Then and Now
- Opportunity Is the Upside of Down Markets
- COVID-19 Just Hit the Accelerator on the Screen-Time Megatrend
- File This Insider Buying Under "Promising News"
Click here for the April issue of Fry’s Investment Report. Best regards, 
Eric Fry
Editor, Fry's Investment Report
P.S. Over the course of my financial career, I have made 41 different recommendations that all went up over 1,000%. Of those, 14 went on to gain more than 2,000%. Of those 14, seven gained more than 5,000%. And I’ve been able to identify these opportunities for huge upside, no matter what the market has been doing. How I do it? I recently hosted a Special Beachside Summit near my home in Southern California to explain exactly that. Check it out here. | 
Great Article, Thank you for sharing such an impressive and useful post
ReplyDeletefry's investment report